MED_RS2 field
- Containing table:
- tblMED
- Explanation of variable:
- Additional reason for stopping treatment
- Format of data:
- character. see coding table for valid codings (identical to stopping reasons for ART)
Coding Table
Most reasons mentioned below could be coded in ICD-10 codes, it is still certain that many reasons will never be defined in terms of ICD-10 (STI, physicians and patients decision), so to avoid a mixture of two different coding systems it is advised to go with the above list and build upon that for now. This list is identical to the stopping reasons for ART (ART_RS)
| Code | Reason for Stopping Treatment |
|---|---|
| 1 | Treatment failure (i.e. virological, immunological, and/or clinical failure |
| 1.1 | Virological failure |
| 1.2 | Partial virological failure |
| 1.3 | Immunological failure - CD4 drop |
| 1.4 | Clinical progression |
| 1.5 | Resistance (based on test result) |
| 10 | Hyperlactataemie/lactic acidosis |
| 11 | Bone toxicity |
| 15 | Social contra-indication |
| 16 | Contra-indication unspecified |
| 16.8 | Contra-indication expired |
| 16.9 | Contra-indication – other |
| 17 | MTCT regimen completed |
| 2 | Abnormal fat redistribution |
| 3 | Concern of cardiovascular disease |
| 3.1 | Dyslipidaemia |
| 3.2 | Cardiovascular disease |
| 4 | Hypersensitivity reaction (skin eruption etc.) |
| 5 | Toxicity, predominantly from abdomen/G-I tract |
| 5.1 | Toxicity - GI tract |
| 5.2 | Toxicity - Liver |
| 5.3 | Toxicity - Pancreas |
| 6 | Toxicity, predominantly from nervous system |
| 6.1 | Toxicity - peripheral neuropathy |
| 6.2 | Toxicity - neuropsychiatric |
| 6.3 | Toxicity - headache |
| 7 | Toxicity, predominantly from kidneys |
| 70 | Pregnancy - toxicity concerns (during pregnancy) |
| 75 | Pregnancy - switch to a more appropriate regimen for PMTCT |
| 8 | Toxicity, predominantly from endocrine system |
| 8.1 | Diabetes |
| 88 | Death |
| 9 | Haematological toxicity (anemia etc.) |
| 90 | Side effects - any of the above but unspecified |
| 90.1 | Comorbidity |
| 91 | Toxicity, not mentioned above |
| 91.1 | Toxicity, unspecified |
| 92 | Availability of more effective treatment (not specifically failure or side effect related) |
| 92.1 | Simplified treatment available |
| 92.2 | Treatment too complex |
| 92.3 | Drug interaction |
| 92.31 | Drug interaction - commencing TB/BCG treatment |
| 92.32 | Drug interaction - ended TB/BCG treatment |
| 92.33 | Change in eligibility criteria (e.g. child old enough for tablets; refrigerator no longer available) |
| 92.4 | Protocol change |
| 92.5 | Regular treatment termination (used in tblMED e.g. for DAA's against HCV, antibiotics) |
| 92.6 | End of empiric treatment |
| 92.9 | Change in treatment not due to side-effects, failure, poor adherence or contra-indication |
| 93 | Structured Treatment Interruption (STI) |
| 93.1 | Structured Treatment Interruption (STI) - at high CD4 |
| 94 | Patient's wish/decision, not specified above |
| 94.1 | Non-compliance |
| 94.2 | Defaulter |
| 95 | Physician's decision, not specified above |
| 96 | Pregnancy (see also more specific codes 70 and 75 |
| 96.1 | Pregnancy intended |
| 96.2 | Pregnancy ended |
| 97 | Study treatment |
| 97.1 | Study treatment commenced |
| 97.2 | Study treatment completed |
| 97.6 | Drug not available |
| 98 | Other causes, not specified above |
| 99 | Unknown |